Portable eye imaging device OIS EyeScan gets US FDA approval: Ophthalmic Imaging Systems

OIS EyeScan can image both the anterior and posterior segment of the eye

OIS EyeScan, a portable device that is capable of imaging both the anterior and posterior segment of the eye, has been approved for marketing by US FDA, accrording to Ophthalmic Imaging Systems, maker of the device.

OIS EyeScanhas received 510(k) market clearance from the U.S. Food and Drug Administration (FDA), Ophthalmic Imaging Systems said.

The OIS EyeScan is the only portable imaging device that is capable of imaging both the anterior and posterior segment of the eye. Powered by OIS WinStation Software, and fully integrated with the OIS Symphony Image Management Solution, OIS EyeScan will deliver more functionality than has ever been available in an imaging device, the company said.

With the ability to capture images from a customized chin rest, from a slit lamp adapter or as a handheld device, the OIS EyeScan is versatile enough to add value to any ophthalmologist’s practice.

The OIS EyeScan has also been designed to be small enough to fit easily in the trunk of a car, and portable enough to be used at multiple locations in one day.

“The EyeScan brings an entirely new level of versatility to ophthalmologists’ offices, and is unlike any other single diagnostic imaging device ever released,” stated Gil Allon, chief executive officer of OIS, in a company release.

Ophthalmic Imaging Systems is the leading provider of ophthalmic digital imaging systems. The Company designs, develops, manufactures and markets digital imaging systems, image management and integrated EMR/Practice Management solutions for the eye care market.

Through OIS’ wholly-owned subsidiary, Abraxas Medical Solutions, the company provides Electronic Medical Records and Practice Management software to Ophthalmology as well as OB/GYN, Orthopedic and Primary care.